The advisory panel overseeing the National Medicines Policy review has presented its revised document in what was a heavily scripted, defensive and at times confused stakeholder webinar during which it was also confirmed they will present advice on a range of other but related issues to health minister Greg Hunt. …
NMP panel host a scripted, defensive and at times confused stakeholder webinar
February 10, 2022 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
BMS therapy secures Australian approval for psoriatic arthritis
September 3, 2026 - -
The live lesson from the UK on who holds the levers and how they use them
September 3, 2026 - -
Gilead returns to Medicines Australia as industry prepares to make the case for innovation
September 3, 2026 - - Latest News -
Combined monitoring of key indicators as the future of diabetes care
September 3, 2026 - -
ENA Respiratory secures funding to test antiviral nasal spray in people with asthma
September 2, 2026 - -
OncoSil pursues a reimbursement pathway as it prepares for US rollout
September 2, 2026 - - Australian Biotech -
Vitrafy takes its cryopreservation technology into the US cell therapy market
September 2, 2026 - - Australian Biotech